Department of Emergency, The Fourth Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, Hebei, China.
Department of General practice, The Fourth Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, Hebei, China.
Technol Health Care. 2022;30(4):869-880. doi: 10.3233/THC-213597.
Stereotactic radiotherapy (SBRT) is widely used in the treatment of thoracic cancer.
To evaluate the efficacy of a non-rebreather mask (NRBM) and high-flow nasal cannula (HFNC) in patients with radiation pneumonia complicated with respiratory failure.
This was a single-center randomized controlled study. Patients admitted to the EICU of the Fourth Hospital of Hebei Medical University were selected and divided into NRBM and HFNC group. Arterial blood gas analysis, tidal volume, respiratory rates and the cases of patients receiving invasive assisted ventilation were collected at 0, 4, 8, 12, 24, 48, and 72 h after admission.
(1) The PaO2/FiO2, respiratory rates, and tidal volume between the two groups at 0, 4, 8, 12, 24, 48, and 72 h were different, with F values of 258.177, 294.121, and 134.372, all P< 0.01. These indicators were different under two modes of oxygenation, with F values of 40.671, 168.742, and 55.353, all P< 0.01, also varied with time, with an F value of 7.480, 9.115, and 12.165, all P< 0.01. (2) The incidence of trachea intubation within 72 h between HFNC and NRBM groups (23 [37.1%] vs. 34 [54.0%], P< 0.05). The transition time to mechanical ventilation in the HFNC and NRBM groups (55.3 ± 3.2 h vs. 45.9 ± 3.6 h, P< 0.05). (3) The risk of intubation in patients with an APACHE-II score > 23 was 2.557 times than score ⩽ 23, and the risk of intubation in the NRBM group was 1.948 times more than the HFNC group (P< 0.05).
Compared with the NRBM, HFNC can improve the oxygenation state of patients with radiation pneumonia complicated with respiratory failure in a short time, and reduce the incidence of trachea intubation within 72 h.
立体定向放疗(SBRT)广泛应用于胸部癌症的治疗。
评估无重复呼吸面罩(NRBM)和高流量鼻导管(HFNC)在放射性肺炎合并呼吸衰竭患者中的疗效。
这是一项单中心随机对照研究。选取河北医科大学第四医院 EICU 收治的患者,分为 NRBM 和 HFNC 组。采集患者入院后 0、4、8、12、24、48、72 h 的动脉血气分析、潮气量、呼吸频率及需要行有创辅助通气的例数。
(1)两组患者在 0、4、8、12、24、48、72 h 的 PaO2/FiO2、呼吸频率、潮气量不同,F 值分别为 258.177、294.121、134.372,均 P<0.01。两种给氧方式下的上述指标不同,F 值分别为 40.671、168.742、55.353,均 P<0.01,且随着时间的变化而不同,F 值分别为 7.480、9.115、12.165,均 P<0.01。(2)HFNC 组和 NRBM 组在 72 h 内气管插管的发生率分别为 23(37.1%)和 34(54.0%),P<0.05。HFNC 组和 NRBM 组机械通气的转换时间分别为 55.3±3.2 h 和 45.9±3.6 h,P<0.05。(3)APACHE-II 评分>23 患者的插管风险是评分 ⩽23 患者的 2.557 倍,NRBM 组的插管风险是 HFNC 组的 1.948 倍,P<0.05。
与 NRBM 相比,HFNC 可在短时间内改善放射性肺炎合并呼吸衰竭患者的氧合状态,降低 72 h 内气管插管的发生率。